Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Armstrong

Showing results (521-530 of 925) with videos related to

Pageof 93
Sort By:
Annals of the Royal College of Surgeons of England|January 1, 1993
Will screening for breast cancer reduce mortality? Evidence from the first year of screening in AvonS Nicholson, A J Webb, B Coghlan, et al.
Traffic (Copenhagen, Denmark)|November 4, 2004
Ncr1p, the yeast ortholog of mammalian Niemann Pick C1 protein, is dispensable for endocytic transportShaochong Zhang, Jihui Ren, Hongzhe Li, et al.
Malaria Journal|March 20, 2013
T1BT* structural study of an anti-plasmodial peptide through NMR and molecular dynamicsElena Topchiy, Geoffrey S Armstrong, Katherine I Boswell, et al.
The Journal of Biological Chemistry|April 19, 2014
Residue histidine 50 plays a key role in protecting α-synuclein from aggregation at physiological pHYing-Chih Chi, Geoffrey S Armstrong, David N M Jones, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Activity of ACHN-490 tested alone and in combination with other agents against Pseudomonas aeruginosaGlenn A Pankuch, Gengrong Lin, Aya Kubo, et al.
Journal of Cancer Research and Clinical Oncology|September 10, 1999
Phase I/II trial of human recombinant granulocyte-colony-stimulating factor (filgrastim) and escalating doses of cyclophosphamide, mitoxantrone, and 5-FU in the treatment of advanced breast cancerG T Budd, J Atiba, R T Silver, et al.
British Journal of Haematology|December 22, 1999
Variable inhibition of placental IgG transfer in vitro with commercial IVgG preparationsS J Urbaniak, J I Duncan, S S Armstrong-Fisher, et al.
Frontiers in Public Health|May 22, 2023
Blood-based biomarkers of frailty in solid tumors: a systematic reviewDilorom Sass, Brennan Parmelee Streck, Vivian A Guedes, et al.
Journal of Consulting and Clinical Psychology|July 28, 2010
Randomized trial of MST and ARC in a two-level evidence-based treatment implementation strategyCharles Glisson, Sonja K Schoenwald, Anthony Hemmelgarn, et al.
Hematology/Oncology Clinics of North America|October 29, 2021
Neurocognition and Health-Related Quality of Life Among Patients with Brain TumorsKyle Noll, Amanda L King, Linda Dirven, et al.
Pageof 93

Showing results (521-530 of 925) with videos related to

Sort By:
Pageof 93
Annals of the Royal College of Surgeons of England|January 1, 1993
Will screening for breast cancer reduce mortality? Evidence from the first year of screening in AvonS Nicholson, A J Webb, B Coghlan, et al.
Traffic (Copenhagen, Denmark)|November 4, 2004
Ncr1p, the yeast ortholog of mammalian Niemann Pick C1 protein, is dispensable for endocytic transportShaochong Zhang, Jihui Ren, Hongzhe Li, et al.
Malaria Journal|March 20, 2013
T1BT* structural study of an anti-plasmodial peptide through NMR and molecular dynamicsElena Topchiy, Geoffrey S Armstrong, Katherine I Boswell, et al.
The Journal of Biological Chemistry|April 19, 2014
Residue histidine 50 plays a key role in protecting α-synuclein from aggregation at physiological pHYing-Chih Chi, Geoffrey S Armstrong, David N M Jones, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Activity of ACHN-490 tested alone and in combination with other agents against Pseudomonas aeruginosaGlenn A Pankuch, Gengrong Lin, Aya Kubo, et al.
Journal of Cancer Research and Clinical Oncology|September 10, 1999
Phase I/II trial of human recombinant granulocyte-colony-stimulating factor (filgrastim) and escalating doses of cyclophosphamide, mitoxantrone, and 5-FU in the treatment of advanced breast cancerG T Budd, J Atiba, R T Silver, et al.
British Journal of Haematology|December 22, 1999
Variable inhibition of placental IgG transfer in vitro with commercial IVgG preparationsS J Urbaniak, J I Duncan, S S Armstrong-Fisher, et al.
Frontiers in Public Health|May 22, 2023
Blood-based biomarkers of frailty in solid tumors: a systematic reviewDilorom Sass, Brennan Parmelee Streck, Vivian A Guedes, et al.
Journal of Consulting and Clinical Psychology|July 28, 2010
Randomized trial of MST and ARC in a two-level evidence-based treatment implementation strategyCharles Glisson, Sonja K Schoenwald, Anthony Hemmelgarn, et al.
Hematology/Oncology Clinics of North America|October 29, 2021
Neurocognition and Health-Related Quality of Life Among Patients with Brain TumorsKyle Noll, Amanda L King, Linda Dirven, et al.
Pageof 93